Cargando…

Radiotherapy induces responsiveness of a resistant mammary carcinoma to PD-1 blockade

Detalles Bibliográficos
Autores principales:	Diamond, Julie, Pilones, Karsten, Aryankalayil, Joseph, Vatner, Ralph, Formenti, Silvia, Demaria, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288536/ http://dx.doi.org/10.1186/2051-1426-2-S3-P159

Ejemplares similares

Combination of interleukin-15 and fractionated radiotherapy for cancer treatment
por: Aryankalayil, Joseph, et al.
Publicado: (2014)

Dendritic cells cross-presenting tumor-derived antigens are eliminated by invariant natural killer T (iNKT) cells, impairing development of anti-tumor immunity to a mouse carcinoma
por: Pilones, Karsten A, et al.
Publicado: (2013)

Intratumoral IL-15 potentiates radiation-induced anti-tumor immunity
por: Pilones, Karsten, et al.
Publicado: (2015)

Unique changes in the TCR repertoire of tumor-infiltrating lymphocytes underlie the synergy of radiotherapy with CTLA-4 blockade
por: Pilones, Karsten, et al.
Publicado: (2014)

Fractionated but not single dose radiation releases key signals of in situ tumor vaccination
por: Vanpouille-Box, Claire, et al.
Publicado: (2014)

The abscopal effect of local radiotherapy is induced by TGFβ blockade
por: Diamond, Julie, et al.
Publicado: (2013)

Mechanisms of synergy of radiotherapy and immunotherapy
por: Pilones, Karsten A, et al.
Publicado: (2015)

Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
por: Pilones, Karsten A., et al.
Publicado: (2012)

Invariant natural killer T cells regulate anti-tumor immunity by controlling the population of dendritic cells in tumor and draining lymph nodes
por: Pilones, Karsten A, et al.
Publicado: (2014)

Ionizing radiation modifies immune-related molecular profiles of tumor-derived exosomes
por: Diamond, Julie M, et al.
Publicado: (2015)

Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade
por: Pilones, Karsten A., et al.
Publicado: (2020)

TGFβ and activin A control regulatory T cells in irradiated tumors
por: Vanpouille-Box, Claire, et al.
Publicado: (2015)

Exploiting the stress response to radiation to sensitize poorly immunogenic tumors to anti-CTLA-4 treatment
por: Demaria, Sandra, et al.
Publicado: (2013)

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
por: Vanpouille-Box, Claire, et al.
Publicado: (2017)

Activin A is upregulated by radiation in breast cancer cells and promotes conversion of CD4 T cells into regulatory T cells
por: Vanpouille-Box, Claire, et al.
Publicado: (2013)

Preclinical to clinical translation of anti-PD-1 blockade
por: Hirsch, Heather, et al.
Publicado: (2015)

Immune induction strategies to enhance responses to PD-1 blockade: lessons from the TONIC trial
por: Demaria, Sandra, et al.
Publicado: (2019)

IL15 synergizes with radiotherapy to reprogram the tumor immune contexture through a dendritic cell connection
por: Pilones, Karsten A., et al.
Publicado: (2020)

Innate resistance of PD-1 blockade through loss of function mutations in JAK resulting in inability to express PD-L1 upon interferon exposure
por: Shin, Daniel, et al.
Publicado: (2015)

PD-1 blockade reverses viral infection-induced loss of anti-tumor CD8+ T cell responses
por: Huelsmann, Erica, et al.
Publicado: (2013)

MAP kinase inhibitors stimulate T cell and anti-tumor activity in combination with blockade of the PD-L1/PD-1 interaction
por: Irving, Bryan A, et al.
Publicado: (2013)

The extent of metalloproteinase-mediated LAG3 cleavage limits the efficacy of PD1 blockade
por: Andrews, Lawrence P, et al.
Publicado: (2015)

Combinations of Immunotherapy and Radiation in Cancer Therapy
por: Vatner, Ralph E., et al.
Publicado: (2014)

Combined radiotherapy and immunotherapy using CPG oligodeoxynucleotides and indolamine 2,3 dioxygenase (IDO) blockade
por: Monjazeb, Arta M, et al.
Publicado: (2013)

Local control by radiotherapy: is that all there is?
por: Formenti, Silvia C, et al.
Publicado: (2008)

Variable density of CD8+ and CD25+ programmed cell death-1 (PD-1) ligand (PD-L1) CD4+ T cells within the tumor microenvironment causes differential responses to the PD-1/PD-L1 blockade
por: Wu, Si-Pei, et al.
Publicado: (2015)

Role of T lymphocytes in tumor response to radiotherapy
por: Demaria, Sandra, et al.
Publicado: (2012)

Enhanced anti-tumor effects of the PD-1/PD-L1 blockade by combining a highly absorptive form of NF-kB/STAT3 inhibitor curcumin
por: Hayakawa, Taeko, et al.
Publicado: (2014)

Selinexor, a selective inhibitor of nuclear export (SINE), shows enhanced activity in combination with PD-1/PD-L1 blockade in syngeneic murine models of colon cancer and melanoma
por: Farren, Matthew R, et al.
Publicado: (2015)

Overall survival of metastatic melanoma patients treated with HD IL-2 followed by immune checkpoint blockade of the CTLA-4 or the PD-1 pathways: analysis of data on the current use of HD IL-2
por: Wong, Michael KK, et al.
Publicado: (2015)

PD-1 blockade upregulate TIM-3 expression as a compensatory regulation of immune check point receptors in HNSCC TIL
por: Shayan, Gulidanna, et al.
Publicado: (2015)

Radiotherapy Effects on Anti-Tumor Immunity: Implications for Cancer Treatment
por: Demaria, Sandra, et al.
Publicado: (2013)

Sequential tumor and dual immune targeted immunotherapy: anti-lymphoma activity of Rituximab with 4-1bb stimulation and PD-1 blockade
por: Mueller, Antonia MS, et al.
Publicado: (2014)

Relationship between immune gene signatures and clinical response to PD-1 blockade with pembrolizumab (MK-3475) in patients with advanced solid tumors
por: Ayers, Mark, et al.
Publicado: (2015)

Can abscopal effects of local radiotherapy be predicted by modeling T cell trafficking?
por: Demaria, Sandra, et al.
Publicado: (2016)

Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models
por: Spahn, Jessica, et al.
Publicado: (2015)

Current clinical trials testing the combination of immunotherapy with radiotherapy
por: Kang, Josephine, et al.
Publicado: (2016)

P16-08. Combined blockade of the PD-1 and IL-10 pathways synergistically enhance HIV-specific CD4 T cell functions
por: Porichis, F, et al.
Publicado: (2009)

Evaluation of ATM protein expression in canine mammary tumors
por: Raposo, Talita MM, et al.
Publicado: (2013)

Expression of STAT1 target genes and interferon gamma in human mammary carcinoma tissue
por: Doppler, W, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_99pl6lrnprlsh2ne1apbdairiq